MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDA • CA55293N1096

Current stock price

36.95 CAD
-1.5 (-3.9%)
Last:

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • MDA had positive earnings in the past year.
  • MDA had a positive operating cash flow in the past year.
  • MDA had positive earnings in each of the past 5 years.
  • In the past 5 years MDA always reported a positive cash flow from operatings.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • MDA has a worse Return On Assets (3.23%) than 69.23% of its industry peers.
  • The Return On Equity of MDA (8.01%) is better than 84.62% of its industry peers.
  • MDA's Return On Invested Capital of 5.52% is on the low side compared to the rest of the industry. MDA is outperformed by 61.54% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 9.52%.
  • The last Return On Invested Capital (5.52%) for MDA is above the 3 year average (4.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROIC 5.52%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • MDA has a worse Profit Margin (6.64%) than 61.54% of its industry peers.
  • MDA's Profit Margin has improved in the last couple of years.
  • MDA's Operating Margin of 9.66% is on the low side compared to the rest of the industry. MDA is outperformed by 61.54% of its industry peers.
  • MDA's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 25.09%, MDA is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MDA has grown nicely.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MDA.CA Health Analysis

2.1 Basic Checks

  • MDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • MDA has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MDA has more shares outstanding
  • Compared to 1 year ago, MDA has a worse debt to assets ratio.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MDA has an Altman-Z score of 1.89. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MDA has a better Altman-Z score (1.89) than 84.62% of its industry peers.
  • The Debt to FCF ratio of MDA is 3.11, which is a good value as it means it would take MDA, 3.11 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.11, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.29, MDA is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Altman-Z 1.89
ROIC/WACC0.61
WACC9.04%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • MDA has a Current Ratio of 0.47. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.47, MDA is doing worse than 84.62% of the companies in the same industry.
  • A Quick Ratio of 0.45 indicates that MDA may have some problems paying its short term obligations.
  • MDA's Quick ratio of 0.45 is on the low side compared to the rest of the industry. MDA is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.45
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MDA.CA Growth Analysis

3.1 Past

  • MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.57%, which is quite impressive.
  • MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 81.71% yearly.
  • Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 51.21%.
  • Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 40.76% on average per year.
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%

3.2 Future

  • Based on estimates for the next years, MDA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.39% on average per year.
  • Based on estimates for the next years, MDA will show a quite strong growth in Revenue. The Revenue will grow by 11.93% on average per year.
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.84%
Revenue Next 2Y11.93%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.99 indicates a quite expensive valuation of MDA.
  • MDA's Price/Earnings ratio is a bit more expensive when compared to the industry. MDA is more expensive than 61.54% of the companies in the same industry.
  • MDA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 24.43, MDA is valued on the expensive side.
  • 61.54% of the companies in the same industry are cheaper than MDA, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, MDA is valued at the same level.
Industry RankSector Rank
PE 27.99
Fwd PE 24.43
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 69.23% of the companies in the same industry are cheaper than MDA, based on the Enterprise Value to EBITDA ratio.
  • 69.23% of the companies in the same industry are cheaper than MDA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.38
EV/EBITDA 16.53
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as MDA's earnings are expected to grow with 14.39% in the coming years.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y14.39%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • MDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (3/26/2026, 7:00:00 PM)

36.95

-1.5 (-3.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.67B
Revenue(TTM)1.63B
Net Income(TTM)108.50M
Analysts80
Price Target48.2 (30.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-40.3%
Max EPS beat(2)13%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)11.19%
EPS beat(12)10
Avg EPS beat(12)26.46%
EPS beat(16)13
Avg EPS beat(16)60.97%
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)0.35%
Max Revenue beat(2)6.49%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)6.87%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)2.95%
Revenue beat(16)12
Avg Revenue beat(16)2.63%
PT rev (1m)2.59%
PT rev (3m)22.13%
EPS NQ rev (1m)-4.85%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)-2.12%
EPS NY rev (3m)-2.92%
Revenue NQ rev (1m)-1.16%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)-0.89%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 27.99
Fwd PE 24.43
P/S 2.86
P/FCF 35.38
P/OCF 11.47
P/B 3.45
P/tB N/A
EV/EBITDA 16.53
EPS(TTM)1.32
EY3.57%
EPS(NY)1.51
Fwd EY4.09%
FCF(TTM)1.04
FCFY2.83%
OCF(TTM)3.22
OCFY8.72%
SpS12.91
BVpS10.71
TBVpS-2.55
PEG (NY)1.92
PEG (5Y)N/A
Graham Number17.84
Profitability
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROCE 7.74%
ROIC 5.52%
ROICexc 5.97%
ROICexgc 53.8%
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
FCFM 8.09%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
ROICexc(3y)4.93%
ROICexc(5y)3.95%
ROICexgc(3y)28.38%
ROICexgc(5y)20.74%
ROCE(3y)6.39%
ROCE(5y)5.17%
ROICexgc growth 3Y61.99%
ROICexgc growth 5YN/A
ROICexc growth 3Y16.02%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Debt/EBITDA 1.31
Cap/Depr 195.88%
Cap/Sales 16.86%
Interest Coverage 10.52
Cash Conversion 136.56%
Profit Quality 121.75%
Current Ratio 0.47
Quick Ratio 0.45
Altman-Z 1.89
F-Score5
WACC9.04%
ROIC/WACC0.61
Cap/Depr(3y)221.3%
Cap/Depr(5y)203.76%
Cap/Sales(3y)19.79%
Cap/Sales(5y)21.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%
Revenue Next Year10.84%
Revenue Next 2Y11.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.75%
EBIT growth 3Y28.37%
EBIT growth 5YN/A
EBIT Next Year118.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.51%
FCF growth 3YN/A
FCF growth 5Y25.11%
OCF growth 1Y-50.04%
OCF growth 3Y92.64%
OCF growth 5Y48.51%

MDA SPACE LTD / MDA.CA Fundamental Analysis FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 4 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 1 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


What is the profitability of MDA stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


What is the financial health of MDA SPACE LTD (MDA.CA) stock?

The financial health rating of MDA SPACE LTD (MDA.CA) is 4 / 10.


What is the earnings growth outlook for MDA SPACE LTD?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 14.58% in the next year.